Body Handbook Catalogue Profile Ranking
Healthcare BODY HANDBOOK
Healthcare ยท ยง609
Barrier Contraception
The condom is the only contraceptive that stops pregnancy and infection in one act, with no hormones and no prescription. But the number on the box misleads: 2% pregnancy a year is the device on a test bench; the real rate for how people actually use them is 13% Sundaram 2017. That gap is fixable, and it comes down to a handful of habits. Once a barrier is the routine, the background hum of scares and second-guessing goes quiet.
Do ยท As-needed Evidence Strong Chapter Healthcare

Latex and polyisoprene block every sexually transmitted virus and bacterium, HIV and hepatitis B included 1. Lambskin condoms are the trap: sold as natural and premium, their pores pass viruses. They stop pregnancy but not infection.

Two questions, two answers. On pregnancy, condoms are mid-tier: excellent used right, mediocre in practice 2. On infection, nothing else competes, because nothing else does it at all. Consistent use cuts HIV transmission by about 80%, and everything else in proportion to the skin the barrier covers 1. The catch is that word: inconsistent use dropped HIV infections by nothing measurable, in serodiscordant couples 3 and in men who have sex with men alike 4. Every-time use even ran 70% lower HPV 5. Consistency is the whole method.

The gap between 2% and 13% is almost all one thing: how it goes on. The condom belongs on before any genital contact, well before climax โ€” pre-ejaculate carries sperm.

And store it where it gets reached for. The most common failure in the literature isn't a tear; it's the condom two rooms away that never got used.

For most readers the real question isn't which method but which to combine. On pregnancy alone the IUD and implant beat barriers by an order of magnitude 2, but none of those cover infection. So: barrier every act with a new partner until both test through the window periods; once infection is ruled out with a long-term partner, a LARC takes pregnancy off the critical path and the barrier comes off. PrEP cuts HIV risk but covers neither bacterial STIs nor pregnancy.

What actually shifts.

  • Within weeks: the day-after check loses its rationale, and the hour-later second-guessing loses its hook.
  • Coming off hormonal contraception: the cycle returns within weeks, and some report a libido or mood lift they only notice once it's back.
  • Across years: the chlamydia that would have ascended, the HPV that would have shown up on a screen, the HIV that never arrives. The payoff is the quiet absence of things that never happened.
The fine print โ€” when to skip it, and what people get wrong

Doubling up is worse, not safer: two condoms add friction and breakage and stack no protection. Spermicide-coated condoms add nothing: the nonoxynol-9 irritates mucosa and in frequent users raises HIV risk 6. "He was tested" isn't cover: a negative last week says nothing about exposures since.

Latex allergy (1-6% of adults) rules out latex condoms and dams; polyisoprene, nitrile, and polyurethane fit, though polyurethane breaks a touch more 7. Nonoxynol-9 is contraindicated at elevated HIV risk and for anal use 6.

In diary data, 40% put the condom on late at least once, 15% took it off early, 13% reused one 8. Real-world breakage is 2-4% per act versus 0.4% on a bench โ€” the gap is oil lube, wrong size, and hot storage.

References
  1. 1Holmes KK, Levine R, Weaver M (2004). Effectiveness of condoms in preventing sexually transmitted infections. Bulletin of the World Health Organization. link
  2. 2Trussell J (2011). Contraceptive failure in the United States. Contraception. link
  3. 3Weller S, Davis-Beaty K (2002). Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database of Systematic Reviews. link
  4. 4Smith DK, Herbst JH, Zhang X, Rose CE (2015). Condom Effectiveness for HIV Prevention by Consistency of Use Among Men Who Have Sex With Men in the United States. Journal of Acquired Immune Deficiency Syndromes. link
  5. 5Winer RL, Hughes JP, Feng Q, et al. (2006). Condom use and the risk of genital human papillomavirus infection in young women. New England Journal of Medicine. link
  6. 6Wilkinson D, Tholandi M, Ramjee G, Rutherford GW (2002). Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomised controlled trials. Lancet Infectious Diseases. link
  7. 7Walsh TL, Frezieres RG, Peacock K, Nelson AL, Clark VA, Bernstein L (2003). Evaluation of the efficacy of a nonlatex condom: results from a randomized, controlled clinical trial. Perspectives on Sexual and Reproductive Health. link
  8. 8Crosby RA, Sanders SA, Yarber WL, Graham CA, Dodge B (2002). Condom use errors and problems among college men. Sexually Transmitted Diseases. link
ยท
609